Andrew R Allen
CIK 1374539 · PRESIDENT AND CEO · last filed 2025-08-08
Andrew R Allen is a PRESIDENT AND CEO who has filed 47 SEC Form 4 insider transactions across 8 companies since 2007. The most recent filing, for CGEM, was dated Aug 8, 2025. Across all open-market trades the lifetime net is −$11.9M, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
8
47
-$11.93M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CGEM | Director | — | $13.70 | — | $0 | 1 | 2025-08-08 |
| Adaptimmune Therapeutics PLC (ADAP) Delisted | Director | — | $0.06 | — | $0 | 3 | 2024-07-01 |
| Gritstone bio, Inc. (GRTS) Delisted | PRESIDENT AND CEO | 1,310,360 | $0.03 | $42.2K | -$18.2K | 9 | 2024-06-26 |
| TCR2 THERAPEUTICS INC. (TCRR) Delisted | Director | — | $1.48 | — | $0 | 6 | 2023-06-01 |
| Sierra Oncology, Inc. (SRRA) Delisted | Director | 0 | $54.99 | $0 | $108.2K | 7 | 2022-07-01 |
| Epizyme, Inc. (EPZM) Delisted | Director | 20,560 | $1.47 | $30.2K | $0 | 8 | 2021-06-15 |
| Clovis Oncology, Inc. (CLVS) Delisted | See Remarks | 192,519 | $0.08 | $15.6K | -$12.02M | 8 | 2015-03-04 |
| PHARMION CORP (PHRM) Delisted | Chief Medical Officer, EVP | 1,005 | — | — | $0 | 4 | 2007-12-07 |
Recent Filings
47 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-08-08 | CGEM | Grant (A) | — | $0 | EDGAR |
| 2024-07-01 | Adaptimmune Therapeutics PLC (ADAP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-06-26 | Gritstone bio, Inc. (GRTS) Delisted | Gift (G) | −650,000 | $0 | EDGAR |
| 2024-05-17 | Gritstone bio, Inc. (GRTS) Delisted | Mixed | +23,610 | -$18.2K | EDGAR |
| 2024-02-05 | Gritstone bio, Inc. (GRTS) Delisted | Grant (A) | +105,000 | $0 | EDGAR |
| 2023-07-05 | Adaptimmune Therapeutics PLC (ADAP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-07-03 | Adaptimmune Therapeutics PLC (ADAP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-06-01 | TCR2 THERAPEUTICS INC. (TCRR) Delisted | Disp (D) | — | $0 | EDGAR |
| 2023-02-06 | Gritstone bio, Inc. (GRTS) Delisted | Grant (A) | +738,550 | $0 | EDGAR |
| 2022-12-19 | TCR2 THERAPEUTICS INC. (TCRR) Delisted | Grant (A) | — | $0 | EDGAR |